Reumatizam, Vol. 64 No. suppl. 1, 2017.
Pregledni rad
PSORIASIS
Marija Kaštelan
Sažetak
Psoriasis is a chronic infl ammatory skin disease aff ecting about 2-3% of the world population, and around 1.6%
of the population in Croatia. Nowadays, psoriasis is considered to be a multisystemic infl ammatory disease with a
variety of comorbidities such as hypertension, diabetes, cardiovascular diseases, infl ammatory bowel and eye diseases,
and psychosocial comorbidities. Th e most common comorbidity in psoriasis is psoriatic arthritis, aff ecting about
30-40% of patients, although accurate epidemiological data are not available. Nowadays, the new paradigm of psoriasis
and psoriatic arthritis uses the term psoriatic disease with skin and/or musculoskeletal manifestations. Contemporary
treatment of psoriasis relies on evidence-based medicine including clinical experience, scientifi c evidence, but also
patients’ desires when choosing the appropriate therapy. Biological therapy in the treatment of psoriasis represents a
signifi cant progress compared to classical psoriasis therapy, due to the high effi cacy and safety of new drugs.
Ključne riječi
Psoriasis – diagnosis, genetics, immunology, therapy; Comorbidity; Arthritis, psoriatic; Biological therapy
Hrčak ID:
188334
URI
Datum izdavanja:
25.10.2017.
Posjeta: 4.887 *